HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A clearer view of the molecular complexity of clear cell renal cell carcinoma.

Abstract
The von Hippel-Lindau (VHL) tumor suppressor gene is mutated as an early event in almost all cases of clear cell renal cell carcinoma (ccRCC), the most frequent form of kidney cancer. In this review we discuss recent advances in understanding how dysregulation of the many hypoxia-inducible factor α-dependent and -independent functions of the VHL tumor suppressor protein (pVHL) can contribute to tumor initiation and progression. Recent evidence showing extensive inter- and intratumoral genetic diversity has given rise to the idea that ccRCC should actually be considered as a series of molecularly related, yet distinct, diseases defined by the pattern of combinatorial genetic alterations present within the cells of the tumor. We highlight the range of genetic and epigenetic alterations that recur in ccRCC and discuss the mechanisms through which these events appear to function cooperatively with a loss of pVHL function in tumorigenesis.
AuthorsIan J Frew, Holger Moch
JournalAnnual review of pathology (Annu Rev Pathol) Vol. 10 Pg. 263-89 ( 2015) ISSN: 1553-4014 [Electronic] United States
PMID25387056 (Publication Type: Journal Article, Review)
Chemical References
  • Von Hippel-Lindau Tumor Suppressor Protein
Topics
  • Animals
  • Carcinoma, Renal Cell (genetics, pathology)
  • Genes, Tumor Suppressor
  • Humans
  • Kidney Neoplasms (genetics, pathology)
  • Mutation
  • Von Hippel-Lindau Tumor Suppressor Protein (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: